Stay updated on Pembrolizumab & Romidepsin Combo Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Romidepsin Combo Clinical Trial page.

Latest updates to the Pembrolizumab & Romidepsin Combo Clinical Trial page
- Check6 days agoChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check13 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check20 days agoChange DetectedThe displayed site revision advances from v3.7.0 to v3.7.1, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision: v3.7.0 was added in the page footer, and a broad set of terms and an institution name were removed from the metadata sections. These appear to be administrative cleanup of metadata rather than substantive changes to the study details.SummaryDifference20%

- Check62 days agoChange DetectedThe page's revision label changes from v3.6.5 to v3.6.6, indicating a new version of the page content.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page revision tag was updated to v3.6.5, indicating a deployment of a newer version of the site software. This appears to be a standard maintenance update rather than content changes.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Romidepsin Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Romidepsin Combo Clinical Trial page.